Last reviewed · How we verify
NCT05358132: ARM-ED
ARM-ED: Advanced Respiratory Monitoring Events in Drug Toxicity
trial testing Pneumowave Device placement and data capture in Respiratory Insufficiency in 78 participants. Completed in 7 March 2024.
7 January 2023
Quick facts
| Lead sponsor | NHS Greater Glasgow and Clyde |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 78 |
| Start date | 8 June 2022 |
| Primary completion | 7 January 2023 |
| Estimated completion | 7 March 2024 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Pneumowave Device placement and data capture
Conditions studied
- Respiratory Insufficiency — all drugs for Respiratory Insufficiency →
- Overdose of Opiate — all drugs for Overdose of Opiate →
- Sedative Overdose — all drugs for Sedative Overdose →
- Sedative Toxicity — all drugs for Sedative Toxicity →
Sponsor
NHS Greater Glasgow and Clyde — full company profile →
Who can join
16 and older, any sex, with Respiratory Insufficiency or Overdose of Opiate. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There is a drug-related death crisis in Scotland. The majority of these deaths have involved the misuse of opiates (e.g. heroin) and benzodiazepines (e.g. valium) which cause an individual to stop breathing. The Advanced Respiratory Monitoring Events in Drug Toxicity (ARM-ED) study is a study investigating whether a wearable sensor can help detect problems with breathing in patients who have had drugs or medications that may cause this effect. The study will span a year and will study two groups of patients - those who attend with actual or expected respiratory depression secondary to acute drug toxicity and individuals who have undergone procedural sedation and analgaesia in the Emergency Department.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Utilization and Feasibility of a Wearable Device in Patients With Sedative Effects of Drugs: Protocol for a Prospective Observational Study for the Advanced Respiratory Monitoring Events in Drug Toxicity (ARM-ED) Study.
Dunlop LC, Henderson B, Meredith O, Trueman C, et al · · 2026 · PMID 41855476 · DOI 10.2196/66961
Verify or expand the search:
- PubMed search for NCT05358132
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Respiratory Insufficiency
Currently open trials in the same condition.
- NCT06653166 — Retrospective Data Analysis With the Aim to Determine the Success Rate of Endotracheal Intubation in the First Attempt i · active not recruiting
- NCT06483984 — Noninvasive Ventilation Facemasks Favoring Carbon Dioxide Washout · NA · recruiting
- NCT05906030 — Diaphragm Dysfunction and Ultrasound Perioperatively · recruiting
- NCT06442267 — Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support · Phase 4 · recruiting
- NCT06494215 — Comparison of Different Methods to Calculate Pendelluft by Electrical Impedance Tomography in Mechanically Ventilated Pa · NA · recruiting
Other NHS Greater Glasgow and Clyde trials
Trials by the same sponsor.
- NCT07403890 — Rewiring the Brain-Immune Axis for Chronic Pain Using Transcranial Magnetic Stimulation in Psoriatic Arthritis · NA · not yet recruiting
- NCT07372508 — Glasgow Low-dose CT and AI-based Diagnostics to Case Find Lung Cancer and Other Cardio-respiratory Long-term Conditions · NA · not yet recruiting
- NCT07391280 — Strategy for EArly Recognition of Cancer, COPD & Heart Failure in the Emergency Department · NA · not yet recruiting
- NCT07048184 — Sarcoma Surgery Wound Complications Comparing Usual Versus Negative Pressure Dressing · Phase 2 · not yet recruiting
- NCT06786936 — Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05358132 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NHS Greater Glasgow and Clyde
- Last refreshed: 21 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05358132.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing